Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics

INTRODUCTION: The prognosis of malignant pleural mesothelioma (MPM) is poor, with a median survival of 8–12 months. The ability to predict prognosis in MPM would help clinicians to make informed decisions regarding treatment and identify appropriate research opportunities for patients. The aims of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunatilake, Samal, Lodge, David, Neville, Daniel, Jones, Thomas, Fogg, Carole, Bassett, Paul, Begum, Selina, Kerley, Sumita, Marshall, Laura, Glaysher, Sharon, Elliott, Scott, Stores, Rebecca, Bishop, Lesley, Chauhan, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797245/
https://www.ncbi.nlm.nih.gov/pubmed/33414260
http://dx.doi.org/10.1136/bmjresp-2019-000506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797245/
https://www.ncbi.nlm.nih.gov/pubmed/33414260
http://dx.doi.org/10.1136/bmjresp-2019-000506

Ejemplares similares